documento de ayuda a la toma de decisiones en el manejo ... - FFIS

BIBLIOGRAFIA
(54) Burns A, Jacoby R, Luthert P, Levy R. Cause of death in Alzheimer’s
disease. Age Ageing 1990; 19(5):341-344.
(55) Molsa PK, Marttila RJ, Rinne UK. Survival and cause of death in
Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand
1986; 74(2):103-107.
(56) van der Steen JT, Ooms ME, Mehr DR, van der WG, Ribbe MW. Severe
dementia and adverse outcomes of nursing home-acquired pneumonia:
evidence for mediation by functional and pathophysiological
decline. J Am Geriatr Soc 2002; 50(3):439-448.
(57) van der Steen JT, Ooms ME, van der WG, Ribbe MW. Withholding or
starting antibiotic treatment in patients with dementia and pneumonia:
prediction of mortality with physicians’ judgment of illness severity
and with specific prognostic models. Med Decis Making 2005;
25(2):210-221.
(58) van der Steen JT, Ooms ME, van der WG, Ribbe MW. Pneumonia: the
demented patient’s best friend? Discomfort after starting or withholding
antibiotic treatment. J Am Geriatr Soc 2002; 50(10):1681-1688.
(59) National Institute for Clinical Excellence (NICE). Guidance on the Use of Donepezil,
Rivastigmine and Galantamine for the Treatment of Alzheimer’s
Disease. Technology ApraisalGuidance No 19.January . 2001.
(60) Areosa Sastre A, McShane R, Sherriff F. Memantina para la demencia
(Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus,
2005 Número 3.Oxford: Update Software Ltd.Disponible en: http://
www.update-software.com.(Traducida de The Cochrane Library,
2005 Issue 3.Chichester, UK: John Wiley & Sons, Ltd.).
(61) Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR et al. Efficacy
and safety of donepezil in patients with more severe Alzheimer’s disease:
a subgroup analysis from a randomized, placebo-controlled
trial. Int J Geriatr Psychiatry 2005; 20(6):559-569.
(62) Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA. Atypical
antipsychotic drugs in the treatment of behavioural and psychological
symptoms of dementia: systematic review. BMJ 2004;
329(7457):75.
(63) Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM et
al. Atypical Antipsychotics and Parkinsonism. Arch Intern Med 2005;
165(16):1882-1888.
74